Integral Molecular, Inc.
Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.
Integral Molecular's greatest strength is their diverse scientific team. Their scientists have extensive expertise in membrane proteins, antibodies, structural biology, and virology, which they apply to provide exceptional solutions and tackle challenging therapeutic targets.
Integral Molecular is a research-driven biotechnology company. They offer a broad array of innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes. Their 14,000-square-foot facility is equipped with state-of-the-art molecular biology, cell culture, high-throughput robotic, biosensor, and flow cytometry instrumentation for a wide range of discovery capabilities.
Integral Molecular is strategically located in the heart of Philadelphia's University City Science Center. We are within walking distance of $1B of scientific research, expertise, and infrastructure, including the University of Pennsylvania, Drexel University, Children's Hospital of Philadelphia, Wistar Institute, and Thomas Jefferson University.
Integral membrane proteins include crucial therapeutic targets but are difficult to study due to their structural complexity and inability to be removed from the lipid membrane in conformationally intact states. At Integral Molecular, we develop innovative technologies and products to address these demanding yet important targets.
Founded in 2001, Integral Molecular holds intellectual property rights covering all aspects of its technologies, including core patents licensed exclusively from the University of Pennsylvania.See more